A detailed history of Tarbox Family Office, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Tarbox Family Office, Inc. holds 976 shares of LLY stock, worth $883,650. This represents 0.13% of its overall portfolio holdings.

Number of Shares
976
Previous 980 0.41%
Holding current value
$883,650
Previous $571,000 32.92%
% of portfolio
0.13%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $2,368 - $3,169
-4 Reduced 0.41%
976 $759,000
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $6,302 - $7,429
12 Added 1.24%
980 $571,000
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $6,955 - $9,588
-16 Reduced 1.63%
968 $519,000
Q2 2023

Jul 20, 2023

SELL
$350.74 - $468.98 $1,753 - $2,344
-5 Reduced 0.51%
984 $461,000
Q1 2023

Apr 11, 2023

SELL
$310.63 - $364.82 $310 - $364
-1 Reduced 0.1%
989 $339,000
Q4 2022

Jan 25, 2023

SELL
$321.55 - $374.67 $2,893 - $3,372
-9 Reduced 0.9%
990 $0
Q2 2022

Jul 19, 2022

SELL
$278.73 - $327.27 $5,295 - $6,218
-19 Reduced 1.87%
999 $324,000
Q1 2022

Apr 25, 2022

SELL
$234.69 - $291.66 $32,387 - $40,249
-138 Reduced 11.94%
1,018 $292,000
Q4 2021

Jan 06, 2022

BUY
$224.85 - $279.04 $1,798 - $2,232
8 Added 0.7%
1,156 $319,000
Q3 2021

Oct 12, 2021

SELL
$221.6 - $272.71 $1,551 - $1,908
-7 Reduced 0.61%
1,148 $265,000
Q4 2020

Jan 27, 2021

SELL
$130.46 - $172.63 $1,695 - $2,244
-13 Reduced 1.11%
1,155 $195,000
Q3 2020

Oct 22, 2020

BUY
$146.22 - $169.13 $146 - $169
1 Added 0.09%
1,168 $173,000
Q2 2020

Jul 23, 2020

BUY
$136.42 - $164.18 $5,047 - $6,074
37 Added 3.27%
1,167 $192,000
Q1 2020

Apr 30, 2020

BUY
$119.05 - $147.35 $8,928 - $11,051
75 Added 7.11%
1,130 $157,000
Q4 2019

Jan 31, 2020

SELL
$106.92 - $132.43 $22,346 - $27,677
-209 Reduced 16.53%
1,055 $139,000
Q2 2019

Aug 02, 2019

BUY
$110.79 - $129.32 $7,312 - $8,535
66 Added 5.51%
1,264 $140,000
Q4 2018

Feb 01, 2019

SELL
$105.9 - $118.64 $49,031 - $54,930
-463 Reduced 27.87%
1,198 $139,000
Q2 2018

Jul 31, 2018

BUY
$75.7 - $86.88 $5,601 - $6,429
74 Added 4.66%
1,661 $142,000
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $222 - $262
-3 Reduced 0.19%
1,587 $123,000
Q3 2017

Oct 19, 2017

BUY
$77.07 - $85.54 $122,541 - $136,008
1,590
1,590 $136,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tarbox Family Office, Inc. Portfolio

Follow Tarbox Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tarbox Family Office, Inc. with notifications on news.